The report focuses on the major industry players operating in the South Africa Biosurgery Market and their relative market share. Source segment dominates the South Africa Biosurgery Market and is expected to retain its dominance throughout the forecast period.
Report Code : A01044 | Pages : 180 | Category : Life Sciences
The Asia-Pacific nuclear medicine market size was valued at $4,116.43 million in 2020, and is projected to reach $8,957.89 million by 2028, registering a CAGR of 10.4% from 2021 to 2028.
Report Code : A01062 | Pages : 142 | Category : Life Sciences
The Asia-Pacific IVD market accounted for $13,680 million in 2016, and is estimated to reach at $19,888 million by 2023, growing at a CAGR of 5.4% from 2017 ...
Report Code : A01065 | Pages : 180 | Category : Life Sciences
Intravenous (IV) ibuprofen is a non-steroidal anti-inflammatory drug (NSAID) used to reduce or treat pain, fever, and inflammation occurred due to a disease, operative procedures or trauma, and acute illness.
Report Code : A01078 | Pages : 90 | Category : Life Sciences
The global defibrillator market size was valued at $13,168 million in 2020, and is projected to reach $24,608.3 million by 2030, registering a CAGR of 6.6% from 2021 to 2030.
Report Code : A01115 | Pages : 219 | Category : Life Sciences
The global acute ischemic stroke diagnosis and treatment market was valued at $5.1 billion in 2022, and is projected to reach $9.2 billion by 2032, growing at a CAGR of 6.1% from 2023 to 2032.
Report Code : A01121 | Pages : 228 | Category : Life Sciences
The global medical/diagnostic imaging market was valued at $38.5 billion in 2020, and is projected to reach $68.8 billion by 2030, growing at a CAGR of 5.8% from 2021 to 2030.
Report Code : A01088 | Pages : 160 | Category : Life Sciences
The global biopsy devices market size was valued at $2,728 million in 2018 and is expected to reach $4,310 million by 2026, registering a CAGR of 5.9% during the forecast period.
Report Code : A01108 | Pages : 334 | Category : Life Sciences
The global ultrasound devices market was valued at $9.3 billion in 2022, and is projected to reach $15.4 billion by 2032, growing at a CAGR of 5.2% from 2023 to 2032.
Report Code : A01114 | Pages : 314 | Category : Life Sciences
The global medical device outsourcing market size was valued at $59,723.42 million in 2020, and is projected to reach $137,948.92 million by 2030, registering a CAGR of 8.9% ...
Report Code : A01117 | Pages : 178 | Category : Life Sciences
An influenza vaccine is a vaccine designed to protect against the influenza virus, commonly known as the flu, which comes in trivalent or quadrivalent types, used to treat seasonal and pandemic flu. It is based on egg-based and cell-based technology, used for adults and pediatric as well.
Report Code : A01118 | Pages : 217 | Category : Life Sciences
The global hearing aid market was valued at $8.1 billion in 2023, and is projected to reach $15.1 billion by 2033, growing at a CAGR of 6.6% from 2024 to 2033.
Report Code : A01126 | Pages : 310 | Category : Life Sciences
The global autoinjectors market was valued at $ 1,509.0 million in 2019, and is expected to reach $ 5,732.6 million by 2027, with a CAGR of 18.1% during the forecast period.
Report Code : A01142 | Pages : 225 | Category : Life Sciences
The global cosmetic implants market size was valued at $9,240.80 million in 2020, and is projected to reach $20,541.20 million by 2030, growing at a CAGR of 8.2% from 2021 to 2030.
Report Code : A01144 | Pages : 220 | Category : Life Sciences
The global preimplantation genetics diagnosis (pgd) market was valued at $81,520.20 thousand in 2020, and is projected to reach $217,190.00 thousand by 2030, growing at a CAGR of 10.4% from 2021 to 2030.
Report Code : A01151 | Pages : 160 | Category : Life Sciences
The global multiple sclerosis therapies market size was valued at $22.99 million in 2018, and is projected to reach $28.00 million by 2026, registering a CAGR of 2.5% ...
Report Code : A01119 | Pages : 151 | Category : Life Sciences
The cancer biomarkers market was valued at $10,944.08 million in 2019, and is projected to reach $26,979.50 million by 2027, registering a CAGR of 11.8% from 2020 to 2027.Cancer biomarkers are traceable substances or molecules that indicate the existence of cancerous cells in the body.
Report Code : A01124 | Pages : 338 | Category : Life Sciences
The global leukemia therapeutics market size was valued at $7,818.63 million in 2021 and is estimated to reach $14,162.48 million by 2031, exhibiting a CAGR of 6.1% from 2022 to 2031.
Report Code : A01128 | Pages : 392 | Category : Life Sciences
The lymphoma therapeutics market was valued at $15,691.45 million in 2022 and is projected to reach $35,207.45 million by 2032, registering a CAGR of 8.4% from 2023 to 2032.
Report Code : A01129 | Pages : 481 | Category : Life Sciences
The global cancer vaccines market was valued at $4,188 million in 2019, and is projected to reach $7,303 million by 2027, registering a CAGR of 12.6% from 2020 to 2027.
Report Code : A01134 | Pages : 284 | Category : Life Sciences
The global deep brain stimulation devices market was valued at $881.9 million in 2018, and is projected to reach $2,802.6 million by 2026, registering a CAGR of 15.5%.
Report Code : A01158 | Pages : 204 | Category : Life Sciences
The global diabetes drugs market was valued at $79.3 billion in 2023, and is projected to reach $157.9 billion by 2033, growing at a CAGR of 7.1% from 2024 to 2033.
Report Code : A01159 | Pages : 280 | Category : Life Sciences
The global osteoporosis drugs market accounted for $7,657 million in 2018, and is expected to reach $10,479 million by 2026, registering a CAGR of 3.9% from 2019 to 2026.
Report Code : A01169 | Pages : 230 | Category : Life Sciences
The global pacemaker market size was valued at $4,667.2 million in 2020, and is projected to reach $6,678.2 million by 2030, registering a CAGR of 3.7% from 2021 ...
Report Code : A01136 | Pages : 231 | Category : Life Sciences
The global surgical navigation systems market size was valued at $940.68 Million in 2020, and is projected to reach $1,755.67 Million by 2030, registering a CAGR of 6.4% from 2021 to 2030.
Report Code : A01139 | Pages : 162 | Category : Life Sciences
